Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
2
×
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
2
×
medicare
2
×
national
national blog main
national top stories
new york blog main
new york top stories
nivolumab
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
2
×
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
2
×
wisconsin top stories
What
bio
drug
roundup
alzheimer’s
annual
approval
assessed
attention
biogen’s
biopharmaceutical
biotech
communities
companies
conference
convo
earlier
esmo
europe
failures
germany
hosted
investment
littered
munich
nash
new
news
price
prices
puzzle
remains
research
road
strategy
talk
turned
week
Language
Current search:
medicare
×
startups
×
" wisconsin blog main "
×
abbvie
×
" life sciences "
×
cancer
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More